Author

Yizhou Peter Huang

Van Andel InstituteORCID 0009-0004-5689-0193Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Eve Deering-GardneriD· 2 shared Timothy Junius TricheiD· 2 shared Alexander C. MonovichiD· 1 shared Colton Dysart· 1 shared Connor G Burke· 1 shared Dahlya Kamarudin· 1 shared Darrell P. ChandleriD· 1 shared Hong WeniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Eve Deering-GardnerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

EZH2-driven immune evasion at disease presentation defines atargetable high-risk subset of acute leukemia exemplified byt(16;21) FUS::ERG AML

Nathaniel J. Buteyn, Samantha J LaMantia, Connor G Burke, Vincent J Sartori, Yizhou Peter Huang, Colton Dysart, Eve Deering-Gardner, Zachary J. DeBruine, Dahlya Kamarudin, Darrell P. Chandler, Alexander C. Monovich, Monika W. Perez, Joanna S. Yi, Rhonda E. Ries, Todd A. Alonzo, , Timothy Junius Triche

This paper identifies an EZH2-driven immune evasion phenotype in FUS::ERG AML that is reversible with tazemetostat, offering a potential targeted therapy for high-risk acute leukemia.

Blood Neoplasia · Sep 1, 2026Peer-reviewedCancer Biology

bamSliceR: a Bioconductor package for rapid, cross-cohort variant analysis

Yizhou Peter Huang, Lauren M. Harmon, Eve Gardner, Xiaotu Ma, Josiah Harsh, Zhaoyu Xue, Hong Wen, Marcel Ramos, Sean R. Davis, Timothy J. Triche

bamSliceR enables rapid, cross-cohort variant analysis by extracting and analyzing aligned reads from GDC data, identifying clinically relevant variants in leukemia cohorts.

Bioinformatics Advances · Dec 26, 2024Peer-reviewedBioinformatics